NCIt definition : An oral formulation containing a small-molecule receptor tyrosine kinase inhibitor
of both vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth
factor receptor (PDGFR) with potential antineoplastic activity. TAK-593 selectively
binds to and inhibits VEGFR and PDGFR, which may result in the inhibition of angiogenesis
and tumor cell proliferation.;